5-Azacitidine Plus PD-1/PD-L1 Inhibitor With PD-1/PD-L1 Refractory Tumors

计划入组 35 人 · 首次发布于 2026 年 2 月 11 日

68Ga-NK224 PET Imaging of PD-L1 Expression in Cancers

计划入组 100 人 · 首次发布于 2024 年 12 月 31 日

PD-L1 Specific 68Ga-THP-PD-L1-3 Probe for PET Imaging in Solid Tumors

计划入组 50 人 · 首次发布于 2024 年 4 月 25 日

KINE-PD-28

IHC-72

IHC-001

Paragon 28

United States

Hut 8 Corp

Canada

PD-RX Pharmaceuticals, Inc.

United States

Agilent's PD-L1 IHC 28-8 pharmDx Receives EU Certification for Lung Cancer and Melanoma Diagnostics

FDA Approves Pembrolizumab for Advanced Esophageal Squamous Cell Cancer with PD-L1 Expression

Agilent's MMR IHC Panel PharmDx Receives FDA Approval as Companion Diagnostic for Colorectal Cancer Immunotherapy